IBDEI13A ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18515,0)
 ;;=B16.9^^79^880^60
 ;;^UTILITY(U,$J,358.3,18515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18515,1,3,0)
 ;;=3^Hepatitis B w/o Delta-Agent & w/o Hepatic Coma
 ;;^UTILITY(U,$J,358.3,18515,1,4,0)
 ;;=4^B16.9
 ;;^UTILITY(U,$J,358.3,18515,2)
 ;;=^5000540
 ;;^UTILITY(U,$J,358.3,18516,0)
 ;;=B18.1^^79^880^36
 ;;^UTILITY(U,$J,358.3,18516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18516,1,3,0)
 ;;=3^Chronic Viral Hepatitis B w/o Delta-Agent
 ;;^UTILITY(U,$J,358.3,18516,1,4,0)
 ;;=4^B18.1
 ;;^UTILITY(U,$J,358.3,18516,2)
 ;;=^5000547
 ;;^UTILITY(U,$J,358.3,18517,0)
 ;;=B17.10^^79^880^61
 ;;^UTILITY(U,$J,358.3,18517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18517,1,3,0)
 ;;=3^Hepatitis C w/o Hepatic Coma
 ;;^UTILITY(U,$J,358.3,18517,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,18517,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,18518,0)
 ;;=B18.2^^79^880^37
 ;;^UTILITY(U,$J,358.3,18518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18518,1,3,0)
 ;;=3^Chronic Viral Hepatitis C
 ;;^UTILITY(U,$J,358.3,18518,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,18518,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,18519,0)
 ;;=B17.8^^79^880^107
 ;;^UTILITY(U,$J,358.3,18519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18519,1,3,0)
 ;;=3^Viral Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,18519,1,4,0)
 ;;=4^B17.8
 ;;^UTILITY(U,$J,358.3,18519,2)
 ;;=^5000544
 ;;^UTILITY(U,$J,358.3,18520,0)
 ;;=B18.8^^79^880^38
 ;;^UTILITY(U,$J,358.3,18520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18520,1,3,0)
 ;;=3^Chronic Viral Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,18520,1,4,0)
 ;;=4^B18.8
 ;;^UTILITY(U,$J,358.3,18520,2)
 ;;=^5000549
 ;;^UTILITY(U,$J,358.3,18521,0)
 ;;=B18.9^^79^880^39
 ;;^UTILITY(U,$J,358.3,18521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18521,1,3,0)
 ;;=3^Chronic Viral Hepatitis,Unspec
 ;;^UTILITY(U,$J,358.3,18521,1,4,0)
 ;;=4^B18.9
 ;;^UTILITY(U,$J,358.3,18521,2)
 ;;=^5000550
 ;;^UTILITY(U,$J,358.3,18522,0)
 ;;=B97.89^^79^880^106
 ;;^UTILITY(U,$J,358.3,18522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18522,1,3,0)
 ;;=3^Viral Agents in Disease Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,18522,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,18522,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,18523,0)
 ;;=A69.20^^79^880^75
 ;;^UTILITY(U,$J,358.3,18523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18523,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,18523,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,18523,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,18524,0)
 ;;=A51.0^^79^880^56
 ;;^UTILITY(U,$J,358.3,18524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18524,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,18524,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,18524,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,18525,0)
 ;;=A52.3^^79^880^78
 ;;^UTILITY(U,$J,358.3,18525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18525,1,3,0)
 ;;=3^Neurosyphilis,Unspec
 ;;^UTILITY(U,$J,358.3,18525,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,18525,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,18526,0)
 ;;=A52.9^^79^880^74
 ;;^UTILITY(U,$J,358.3,18526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18526,1,3,0)
 ;;=3^Late Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,18526,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,18526,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,18527,0)
 ;;=A53.9^^79^880^98
 ;;^UTILITY(U,$J,358.3,18527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18527,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,18527,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,18527,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,18528,0)
 ;;=A54.00^^79^880^57
 ;;^UTILITY(U,$J,358.3,18528,1,0)
 ;;=^358.31IA^4^2
